Advertisement

Nuklearmedizinische Tumordiagnostik

  • C. Winkler
Chapter
Part of the Handbuch der medizinischen Radiologie / Encyclopedia of Medical Radiology book series (HDBRADIOL, volume 15 / 3)

Zusammenfassung

Durch die Einführung nuklearmedizinischer Methoden in die klinische Onkologie sind die Möglichkeiten des Tumornachweises und der Verlaufskontrolle bei Geschwulstkrankheiten wesentlich erweitert worden. Zwar haben heute — wie auch in anderen Bereichen der Diagnostik — manche früher gebräuchlichen und durchaus erfolgreich angewandten Verfahren infolge konkurrierender technischer Entwicklungen (z.B. Transmissions-Computertomo-graphie, digitale Subtraktionsangiographie) nicht mehr ihre ursprüngliche Bedeutung. Andererseits konnten jedoch in den letzten Jahren auch in der Nuklearmedizin beachtliche Fortschritte erzielt werden, die u.a. der Tumordiagnostik zugute gekommen sind. Dies gilt für den „klassichen“ Bereich der Anwendung radioaktiver Testpräparate in vivo und in vitro sowie neuerdings auch für die Nutzung anderer kernphysikalischer Methoden, insbesondere der tomographischen und spektrometrischen Nuklearmagnetresonanz-(NMR)-Diagnostik.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Abelev GI (1971) Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv Cancer Res 14:295–358PubMedGoogle Scholar
  2. Aburano T, Tonami N, Hisada K (1974) Combined examinations of hepatic tumor. Proc first World Congr Nucl Med Tokyo: WFNMB, pp 474–476Google Scholar
  3. Adler S, Parthasarathy KL, Bakshi SP, Stutzman L (1975) Gallium-67-Citrate scanning for the localization and staging of lymphomas. J Nucl Med 16:255PubMedGoogle Scholar
  4. Adolphs H-D, Oehr P (1982) Significance of urine and serum CEA determination for the diagnosis of urinary bladder cancer. Tumordiagnostik 3:34Google Scholar
  5. Anger HO (1958) Scintillation camera. Rev Sci Instrum 29:27Google Scholar
  6. Anger K, Feine U, Naumann G, Schwarz J, Völcker HE (1980) Tumordiagnostik am Auge mit Phosphor-32. Nuklearmedizin 4:367Google Scholar
  7. Anghileri LJ (1971) Studies on the accumulation mechanisms of radioisotopes used in tumor diagnostic. Strahlentherapie 4:456–462Google Scholar
  8. Ansari AN, Atkins HL (1977) Radiopharmaceuticals and tumor detection. In: Spencer RP (ed) CRC Handbook series in clinical laboratory science, sect A, I. CRC, Cleveland/OhioGoogle Scholar
  9. Asahara A, Ueda H (1974) Study of hepatic circulation with scintillation camera coupled with medical computer and digital analyzer. Proc World Congr Nucl Med WFNMB, pp 539–541Google Scholar
  10. Bähre M, Franken TH (1981) Knochenszintigraphie bei Osteoarthropathia Pierre-Marie Bamberger In: Feine U (Hrsg) Artdiagnostische Aussagen der Knochenszintigraphie. Symp 23./24.1.1981 in Tübingen. Im DruckGoogle Scholar
  11. Bale WF, Spar IL, Goodland RL (1960) Tumor affinity of antiflbrin antibodies. Cancer Res 20:1488PubMedGoogle Scholar
  12. Bale WF, Spar IL, Goodland RL (1962) Fibrin Antibodies as Tumor Localizing Agents AEC Res. a. Dev.Rep. UR-612Google Scholar
  13. Ballou B, Levine G, Hakala TR (1979) Tumor location detected with radioactively labeled monoclonal antibody and external scintigraphy. Science 206:844–847PubMedGoogle Scholar
  14. Battezzati M, Donini I (1964) The use of radioisotopes in the study of the physiopathology of the lymphatic system. J Cardiovasc Surg (Torino) 5:691Google Scholar
  15. Bauer FK, Steffen CG (1955) Radioactive phosphorus in the diagnosis of skin tumors. JAMA 158:563Google Scholar
  16. Bauer GCH, Wendeberg B (1958) External counting of 47 Ca und 85 Sr in studies of localised skeletal lesions in man. J Bone Joint Surg 40 AGoogle Scholar
  17. Bauer HW, Hackenberg HJ (1962) Ein neuer Fest-phasen-Immunoassay für die prostataspezifische saure Phosphatase. Erste klinische Ergebnisse und Methodik. Tumor Diagnostik 3:138Google Scholar
  18. Baumgarten C, Koischwitz D, Albrecht W, Winkler C (1982) Synopsis von Szintigraphie, Sonographie und Zytologie der Schilddrüse. In: Rösier H, Schmidt HAE (Hrsg) Nuklearmedizin. Schattauer, Stuttgart, S 753Google Scholar
  19. Beierwaltes WH, Lieberman LM, Verma VM (1968) Visualizing human malignant melanoma and metastases. JAMA 206:97PubMedGoogle Scholar
  20. Bekerman C (1982) Inflamation and tumor imaging. In: Greenfield LD, Uszler JM (eds) Nuclear medicine in clinical practice. Chemie Internat, Chicago, p 199Google Scholar
  21. Bell EG, Subramanian G (1979) The skeleton. In: Rocha AFG, Harbert JC (Hrsg) Textbook of Nuclear Medicine: Clinical applications. Lea & Febiger, PhiladelphiaGoogle Scholar
  22. Berson SA, Yalow RS, Baumann A, Rothschild MA, Newerly K (1956) Insulin-131 I-metabolism in human subjects. J Clin Invest 35:170–190PubMedGoogle Scholar
  23. Bessler W (1975) Die Skelettszintigraphie. Ihre diagnostischen Möglichkeiten und Indikation im Vergleich zur Röntgenuntersuchung. Schweiz Med Wochenschr 105:175–180PubMedGoogle Scholar
  24. Bessler W (1978) Szintigraphische Untersuchungen von Knochen und Gelenken. In: Hundeshagen H (Hrsg) Handbuch der Medizinischen Radiologie, Bd XV, Teil 2, Springer, Berlin Heidelberg New YorkGoogle Scholar
  25. Biersack HJ (1977) Neue Aspekte der Leberszintigraphie (Vortrag), Köln-Bonner Röntgenvereinigung „Neue Methoden zur Röntgenuntersuchung der Leber und der Gallenwege“, Bonn, 1977. Röntgenblaetter 30:491Google Scholar
  26. Biersack HJ, Schlieter F (1978) der 32P-Test in der ophthalmologischen Tumordiagnostik. 59. Tagung Dtsch Röntgenges 1978, BonnGoogle Scholar
  27. Biersack HJ, Winkler C (1980) Der Einsatz von Halbleiterzählern zur 32P-Diagnostik von Augen-und Hauttumoren. Nuklearmedizin 4:359Google Scholar
  28. Biersack HJ, Winkler C (1982) Neue Aspekte in Diagnostik und Therapie des Schilddrüsenkarzinoms. Schattauer, Stuttgart New YorkGoogle Scholar
  29. Biersack HJ, Winkler C (1982b) Differenziertes und undifferenziertes Schilddrüsenkarzinom — Behandlungsergebnisse in Bonn. In: Biersack HJ, Winkler C (Hrsg) Neue Aspekte in Diagnostik und Therapie des Schilddrüsenkarzinoms. Schattauer, Stuttgart New York, pp 177–182Google Scholar
  30. Biersack HJ, Winkler C (1982) SPECT of the liver. Ann Meeting Belgian Society of Nucl Med, Nov 1982, BrüsselGoogle Scholar
  31. Bier sack HJ, Bücheier E, Hünermann B, Schulz D, Winkler C (1975) Zirrhose-Karzinom oder Rege-neratknoten? Nuklearmedizinische und röntge-nologische Methoden in der Differentialdiagnose. Röntgenblaetter 28:399–406Google Scholar
  32. Biersack HJ, Rodermund OE, Meurin G, Winkler C (1976) Radiophosphor (32P)-Test bei Präkanzerosen und malignen Tumoren der Haut. Hautarzt 27:133PubMedGoogle Scholar
  33. Biersack HJ, Wegner G, Distelmaier W, Krause U (1980a) Ossäre Metastasierung des Prostatakarzinoms in Abhängigkeit von Tumorgröße und Ge-schwulstdifferenzierung. Nucl Med 19:29Google Scholar
  34. Biersack HJ, Potthoff P, Frommhold H, Winkler C (1980b) Ossäre Metastasierung des Bronchialkarzinoms. Nuc Compact 11:64–66Google Scholar
  35. Biersack HJ, Knopp R, Winkler C (1981) Emissionscomputertomographie. Therapiewoche 31:6067–6079Google Scholar
  36. Biersack HJ, Reske SN, Knopp R, Winkler C (1982a) Optimierung der szintigraphischen Diagnostik durch „Single Photon“ Emissionscomputertomographie — Ergebnisse bei 1300 Patienten. In: Höfer R, Bergmann H (Hrsg) Radioaktive Isotope in Klinik und Forschung. Egermann, Wien, S 123Google Scholar
  37. Biersack HJ, Knopp R, Reske SN, Reichmann K, Winkler C (1982b) Single photon emission tomography (SPECT) as an important complement in routine scintigraphic imaging. In: Raynaud C (ed) Nuclear medicine and biology. Pergamon, Paris Oxford New York Toronto Sydney Frankfurt, p 465Google Scholar
  38. Biersack HJ, Knopp R, Reske SN, Reichmann K, Winkler C (1982c) SPECT as an important complement in routine scintigraphic imaging. Proc III. World Congr Nucl Med, pp 465–468Google Scholar
  39. Björklund B, Björklund V, Hedlöf I (1961) Tissue polypeptide antigen. J Nat Cancer Inst 26:3Google Scholar
  40. Blair RJ, McAfee JG (1976) Radiological of skeletal metastases: radiographs versus scans. Int J Ra-diat Oncol Biol Phys 1:1201Google Scholar
  41. Blanquet P, Dubarry JJ, Beck C (1969) Scintigraphie pancreatique par soustraction electronique. A propos de 200 examens. Press Med 77:1237PubMedGoogle Scholar
  42. Bleehen NM, Bryant THE (1967) In vivo-studies of radioactive phosphorus in malignant tumors, Clin Radiol 18:237PubMedGoogle Scholar
  43. Bloch F (1946) Nuclear induction. Physiol Ref 70:460–473Google Scholar
  44. Blois MS (1968) Melanoma detection with radioio-doquine. J Nucl Med 9:492PubMedGoogle Scholar
  45. Börner W, Grünberg H, Moll E (1967) Die Speichel-drüsenszintigraphie mit 99mTc-Pertechnetat. In: Hoffman G, Scheer KE (Hrsg) Radioisotope in der Lokalisationsdiagnostik. Schattauer, Stuttgart, S 453–458Google Scholar
  46. Börner W, Emrich D, Horster FA, Klein E, Pfannenstiel P, Reinwein D (1977) Diagnostik und Therapie des Solitärknotens der Schilddrüse. Med Welt 28:721PubMedGoogle Scholar
  47. Botsch H (1982) Radioimmunoassay für die Serum-Thyreoglobulin-Bestimmung. Thieme, Stuttgart New YorkGoogle Scholar
  48. Braun-Falco O (1980) Maligne Melanome der Haut. Muench Med Wochenschr 122:191Google Scholar
  49. Breit A, Czempiel H, Koernig-Kron K (1969) Die Lymphoszintigraphie in der Tumor therapie. Strahlentherapie 138:74PubMedGoogle Scholar
  50. Briggs R, McFarlane RG (1957) Fibrin in malignant tissues. Thomas, Springfield/IllGoogle Scholar
  51. Broser J, Kallmann H (1947) Z Naturforsch 29:439Google Scholar
  52. Brown DH, Carlton JE, Hayes RL (1972) Mechanism of gallium — binding in tumors: isolation and characterization of gallium binding-granules (GBG) in softtissue tumors. Proc Am Assoc Cancer Res 13:37Google Scholar
  53. Brown DH, Byrd BL, Carlton JE, Swartzendruber DC, Hayes RL (1976) A quantitative study of the subcellular localization of 67-Ga-1. Cancer Res 36:956–963PubMedGoogle Scholar
  54. Brownell GL, Sweet WH (1953) Localisation of brain tumors with positron emitters. Nucleonics 11:40Google Scholar
  55. Bücheier E, Boldt I, Frommhold H (1973) Leistungsfähigkeit und Grenzen der Leberarteriographie. Fortschritte Roentgenstr 119:530Google Scholar
  56. Budinger TF, Gullberg GT, Huesmann RH (1979) Emission computed tomography. In: Herman GT (ed) Topics of applied physics, vol 32. Springer, Berlin Heidelberg New YorkGoogle Scholar
  57. Burdine JA, Murphy PH, DePuey EG (1979) Radio-nuclide computed tomography of the body usingroutine radiopharmaceuticals. IL clinical applications. J Nucl Med 20:108–114PubMedGoogle Scholar
  58. Calmettes C, Caillou B, Moukhtar S, Milhaud G, Gerard-Marchant R (1982) Calcitonin and carci-noembryonic antigen in poorly differentiated fol-licular carcinoma. Cancer 49:2342PubMedGoogle Scholar
  59. Camargo E, Johnston G, Larson S, Wagner H (1979) Tumor Diagnosis. In: Rocha AG (ed) Textbook of nuclear medicine. Lea & Febiger, PhiladelphiaGoogle Scholar
  60. Cancroft E, Goldfarb R (1981) Breast scintigraphy as an imaging modality in the diagnosis of breast masses. Semin Nucl Med 4:289–300Google Scholar
  61. Cancroft ET, Goldsmith SJ (1973) 99mTc-Pertechne-tate scintigraphy as an aid in the diagnosis of breast masses. Radiology 106:441–444PubMedGoogle Scholar
  62. Cannon JR, Long RF, Berens SV, Caplan GE (1980) Uptake of 99mTc-PIPIDA in pulmonary metastases from a hepatoma. Clin Nucl Med 5:22–24PubMedGoogle Scholar
  63. Cannon PR, Frazier LE, Hughes RA (1952) Influence of K on tissue protein synthesis. Metabolism 1:49PubMedGoogle Scholar
  64. Carvalho N, Harbert JC, Leiva AH de, Mello MT de, Rocha AFG, Tatit ED (1979) The gastrointestinal system. In: Rocha AFG (ed) Textbook of nuclear medicine. Lea & Febiger, PhiladelphiaGoogle Scholar
  65. Cassen B, Curtis L, Reed CW, Libby RL (1951) Instrumentation for 131J use in medical studies. Nucleonics 9:46Google Scholar
  66. Catz B, Petit D, Starr P (1959) The diagnostic and therapeutic value of thyrotropic hormone and heavy dosage scintigrams for the demonstration of thyroid cancer metastases. Am J Med Sci 237:158PubMedGoogle Scholar
  67. Cavalieri RR, Steinberg M (1971) Selenite (75Se) as a tumor scanning agent. J Surg Oncol 3:617Google Scholar
  68. Cavalieri RR, Scott KG, Sairenji E (1966) Selenit (75Se) as a tumor-localizing agent in man. J Nucl Med 7:197PubMedGoogle Scholar
  69. Chaikoff JL (zit n Müller JH) (1961) Künstliche radioaktive Isotope in Physiologie, Diagnostik und Therapie. In: Schwiegk H, Turba F (Hrsg) Bd II. Springer, Berlin Heidelberg New YorkGoogle Scholar
  70. Charkes ND, Sklaroff DM, Young I (1966) A critical analysis of strontium bone scanning for detection of metastatic cancer. Am J Roentgenol 96:647Google Scholar
  71. Charles MB, Beierwaltes WH, Lieberman LM, Bergstrom TJ (1971) I-125 labeled chloroquine analog in the diagnosis of ocular melanomas. J Nucl Med 12:601Google Scholar
  72. Chauncey DM, Halpern SE, Alazraki NP (1974) Ra-dioiodinated tetracyclines : Evaluation as tumor-scanning agents. J Nucl Med 15:483Google Scholar
  73. Chew FS, Hudson TM (1980) Radionuclide imaging of lipoma and liposarcoma. Radiology 136:741–745PubMedGoogle Scholar
  74. Classen B, Curtis L, Reed CW, Villani R (1951) Instrumentation for 131J-use in medical studies. Nucleonic 8:46Google Scholar
  75. Coleman DJ, Lizzi FL, Jack RL (1977) Ultrasonography of the eye and orbit. Lea & Febiger, PhiladelphiaGoogle Scholar
  76. Cramer H, Brilmayer C (1951) Radionuklide in der Krebsdiagnostik. Med Klin 46:809PubMedGoogle Scholar
  77. Cramer H, Pabst HW (1952) Tumordiagnostik mit radioaktiven Isotopen. Z Krebsforsch 58:163Google Scholar
  78. Creutzig H, Hundeshagen H (1970) Pankreasszinti-graphie mit 75Se-Selenmethionin. Med Klin 65:2234PubMedGoogle Scholar
  79. Creutzig H, Hundeshagen H (1971) Die Leistungsgrenze der Pankreasszintigraphie. Dtsch Med Wochenschr 96:1981PubMedGoogle Scholar
  80. Creutzig H, Hundeshagen H (1973) Ergebnisse der Doppelradionuklid-Pankreasszintigraphie. Dtsch Med Wochenschr 98:1019PubMedGoogle Scholar
  81. Creutzig H, Bornemann H, Schulz D, Creutzig A (1980) Tumorszintigraphie beim Menschen mit markierten Fibrinogenen. Nuklearmedizin 3:351–357Google Scholar
  82. Czech W, Canigiani G, Wolf G, Pulitzer B (1974) 67 Gallium in der Tumordiagnostik. Fortschr Roentgenstr 120:413PubMedGoogle Scholar
  83. Damadian R (1971) NMR Scanning for Medical Diagnosis. Science 171:1151PubMedGoogle Scholar
  84. Daver A, Bouali AB, Bertrans G, Larra F (1979) β 2-microglobulin (β 2-micro) and carcinoembryo-nic antigen (CEA) in intestinal cancers — A correlation with stage of disease. In: Lehmann F-G (ed) Carcino-Embryonic proteins, vol II. Elsevier/North-Holland Biomedical Press, Amsterdam New York Oxford, p 611Google Scholar
  85. David NC (1959) Etude comparative fonctionelle et anatomique du foie et des reins par les molecules marquées à les molecules marquées a 1′ I131. Mém Certif Radiol, ParisGoogle Scholar
  86. Davis L (1959) Aids in diagnosis of tumors of central nervous system. In: Pack GT, Ariel IM (eds) Treatment of cancer and allied diseases. Tumors of the nervous system, vol II, 2nd edn. Hoeber, New York, pp 18–31Google Scholar
  87. Day ED, Planisek JA, Korngold L, Pressman D (1956) Accumulation of 131J-labeled tumor antibodies in tumor implants. J Natl Cancer Inst 17:517PubMedGoogle Scholar
  88. Day ED, Planinsek JA, Pressman D (1959) Localization of radioiodinated rat fibrinogen in transplanted rat tumors. J Natl Cancer Inst 23:799–812PubMedGoogle Scholar
  89. Decker D, Trier H-G, Irion KM, Lepper R-D, Reuter R (1980) Rechnergestützte Gewebsdifferenzie-rung am Auge. Ultraschall in der Medizin 1:284Google Scholar
  90. Droese M (1979) Methodische Gesichtspunkte und Treffsicherheit der Feinnadelpunktion der Schilddrüse. Nuklearmedizin 2:111–119Google Scholar
  91. Droese M (1982) Zytologie. In: Biersack HJ, Winkler C (Hrsg) Neue Aspekte in Diagnostik und Therapie des Schilddrüsenkarzinoms. Schattauer, Stuttgart, New YorkGoogle Scholar
  92. Dudley HC, Maddox GE (1949) Deposition of Radiogallium (ga-72) in skeletal tissues. J Pharmacol Exp Ther 96:224PubMedGoogle Scholar
  93. Dudley HC, Munn JI, Henry KE (1950) Studies of the metabolism of Gallium. J Pharmacol Exp Ther 98:105PubMedGoogle Scholar
  94. Duran-Reynals F (1939) Studies on the localizing of dyes in normal and malignant tissues. J Cancer Res 35:98–107Google Scholar
  95. Dymarskij L, Fadeev P (1976) Ergebnisse der para-sternalen Lymphoszintigraphie beim Mamma-karzinom im Lichte anatomisch-morphologischer Befunde. Radiobiol Radiother (Berl) 17:171Google Scholar
  96. Edwards CL, Hayes RL (1969) Tumor scanning with 67Ga-Citrate. J Nucl Med 10:103PubMedGoogle Scholar
  97. Edwards CL, Hayes RL (1970) Scanning malignant neoplasms with gallium-67. JAMA 212:1182PubMedGoogle Scholar
  98. Edwards CL, Hayes RL, Nelson B (1972) The normal 67Ga scan. J Nucl Med 13:428Google Scholar
  99. Ege GN (1976) Internal mammary lymphoscintigra-phy. The rationale, technique, interpretation, and clinical application : a review based on 848 cases. Radiology 118:101PubMedGoogle Scholar
  100. Ehrlich P (1911) Zit nach Wassermann A v, Keysser F, Wassermann M (1912) Farbstoffaufnahme aus dem Blut. Berl Med Wochenschr 49:4Google Scholar
  101. Emrich D (1976) Nuklearmedizinische Diagnostik und Therapie. Thieme, StuttgartGoogle Scholar
  102. Emrich D, Mühlen A v z, Bartholome A, Farino H, Pixberg U (1967) Klinische Erfahrungen und experimentelle Ergebnisse bei der Tumordarstellung mit 197Hg. In: Radioisotope in der Lokalisa-tionsdiagnostik. Schattauer, StuttgartGoogle Scholar
  103. Ernst H, Krüger J, Vessal K (1969) Lung scanning as a screening method for cancer of the lung. Cancer 23:508–512PubMedGoogle Scholar
  104. Eshkar Z, Order SE, Katz D (1974) Ferritin: A Hodgkin’s disease associated antigen. Proc Natl Acad Sci USA 71:3956–3960Google Scholar
  105. Esteban J, Lasa D, Perez-Modrego S (1965) Detection of cartilagionous tumours with selenium-75. Radiology 85:149PubMedGoogle Scholar
  106. Euler VS v, Lilljestrand G (1946) The regulation of respiration during muscular work. Acta Physiol Scand 12:268Google Scholar
  107. Fadejew NP, Gershandwich ML, Jushkantsev SI (1973) O skennirowanii legkich pri limfogranulo-matose (Über die Lungenszintigraphie bei Lym-phogranulomatose). Woprosi Onkologii 14:25–30 (russ mit engl Zusammenf)Google Scholar
  108. Fairbaks VF, Tauxe WN, Kiely J-M, Miller WE (1972) Scintigraphic visualization of abdominal lymph nodes with 99mTc-Pertechnetate-labeled sulfur colloid. J Nucl Med 13:185Google Scholar
  109. Fateh-Moghadam A, Neumeier D, Hannig CH, Otte M, Kruis W (1981) CEA und ß 2-Mikroglobulin in der serologischen Diagnostik des Pankreaskar-zinoms. In: Uhlenbruck G, Wintzer G (Hrsg) CEA — Carcinoembryonales Antigen und andere Tumormarker. Tumordiagnostik, Leonberg, S 390Google Scholar
  110. Fee HJ, Robinson DS, Sample WF, Graham CE, Homes D, Morton L (1978) The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma. A preliminary study. Surgery 84:626PubMedGoogle Scholar
  111. Feine U, Winkel K zum (1980) Nuklearmedizin, Szintigraphische Diagnostik. Thieme, StuttgartGoogle Scholar
  112. Fischer J, Preiß J (1983) Tumormarker. In: Fischer J (Hrsg) Taschenbuch der Onkologie. Urban & Schwarzenberg, München Wien Baltimore, S 112Google Scholar
  113. Fochem K, Ogris E, Breit A, Reindl P, Olbert FO, Fuchs SF, Neumann I (1975) Raumfordernde Nierenprozesse. In: Breit A (Hrsg) Wertigkeit radiologischer Methoden. Thieme, StuttgartGoogle Scholar
  114. Frankel RS, Johnson KW, Marby JJ (1974) „Normal“ bone radionuclide image with diffuse skeletal lymphoma. Radiology 111:365PubMedGoogle Scholar
  115. Fujimoto Y, Oka A, Nagataki S (1972) Occurrence of papillary carcinoma in hyperfunctioning thyroid nodule. Endocrinol Japn 19:371–374Google Scholar
  116. Gadian DG (1981) NMR and its application to living systems. Oxford University PressGoogle Scholar
  117. Galvan G (1979) Feinnadelpunktion der Schilddrüse. Vortrag beim 5. Berner Symposion über „Struma maligna“, Bern, AprilGoogle Scholar
  118. Garlick PB, Radda GK (1980) NMR and its applications to metabolic studies. Techniques in Metabolic Res 216:1–24Google Scholar
  119. Gelbard AS, Benua RS, Laughlin JS, Rosen G, Reiman RE, McDonald JM (1979) Quantitative scanning of osteogenic sarcoma with nitrogen-13-labeled L-glutamate. J Nucl Med 20:782PubMedGoogle Scholar
  120. Gelrud LG, Arseneau JC, Johnston GS (1974) The kinetics of gallium-67 incorporation into inflammatory lesions : experimental and clinical studies. J Lab Clin Med 83:489PubMedGoogle Scholar
  121. Gladisch R (1981) Praxis der abdominellen Ultra-schalldiagnostik. Schattauer, Stuttgart New YorkGoogle Scholar
  122. Glanzmann CH, Lütolf U, Horst W (1977) Therapie und Prognose bei Struma maligna. Erfahrungen bei 216 Patienten aus dem Zeitraum 1962–1976. Therapiewoche 27:59Google Scholar
  123. Gold P, Freedman SO (1965) Demonstration of tumor-specific antigens in human colonic carcino-mata by immunological tolerance and absorption techniques. J Exp Med 121:439PubMedGoogle Scholar
  124. Goldenberg DM, Kim EE, DeLand FH (1980) Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin. Science 208:1284–1286PubMedGoogle Scholar
  125. Grebe SF, Schoen H, Steckenmesser R, Heger N (1972) Die Möglichkeiten des Nachweises und der Lokalisation von malignen Tumoren Fortschr Roentgenstr 116:73–76Google Scholar
  126. Greenfield LD (1978) Thyroid cancer. CRC-Press 1978Google Scholar
  127. Groot LJ de (1974) Most solitary thyroid nodules should be removed. In: Ingeflnger FJ (ed) Controversies in internal medicine II. Saunders, Philadelphia, p 421Google Scholar
  128. Gropp C, Havemann K, Luster W, Lehmann FG (1981a) Carcinoembryonic antigen as parameter for staging and monitoring of therapy in patients with lung cancer. In: Uhlenbruck G, Wintzer G (Hrsg) CEA — Carcinoembryonales Antigen und andere Tumormarker. Tumordiagnostik, Leonberg, S 198Google Scholar
  129. Gropp C, Luster W, Havemann K, Lehmann FG (1981b) ACTH, Calcitonin, α-MSH, β-Endor-phin, Parathormone, and β-UCG in sera of patients with lung cancer. In: Uhlenbruck G, Wintzer G (Hrsg) CEA — Carcinoembryonales Antigen und andere Tumormarker. Tumordiagnostik, Leonberg, S 364Google Scholar
  130. Guiberteau MS, Potsaid MS, McKusick KA (1976) Accumulation of Tc-99m Diphosphonate in four patients with hepatic neoplasm: Case reports. J Nucl Med 17:1060–1061PubMedGoogle Scholar
  131. Guanasekera SW, King LJ, Lavendar PJ (1972) The behavior of tracer gallium-67 towards serum proteins. Clin Chim Acta 39:401Google Scholar
  132. Halie MR, Beekhuis H, Woldring M, Nieweg HO (1969) Scanning with 75-Selenomethionine for the diagnosis of malignant lymphomas. Sympos Ka-mera-Szintigraphie, Springer, HeidelbergGoogle Scholar
  133. Hancke S, Holm HH, Koch F (1975) Ultrasonic guided percutaneous fine needle biopsy of the pancreas. Surg Gynecol Obstet 140:361–364PubMedGoogle Scholar
  134. Handa (1972) Dynamic aspects of Human Brain Scanning. Thieme, StuttgartGoogle Scholar
  135. Hansen HJ, Snyder JJ, Miller E, Vandevoorde JP, Miller ON, Hines LR, Burns JJ (1974) Concentrations of carcinoembryonic antigen in plasma of patients with various malignant diseases (Tab.) Hum Pathol 5:139PubMedGoogle Scholar
  136. Hara T, Taylor C, Lembares N (1971) L-aspartic acid-4-11C for tumor scanning. J Nucl Med 12:361 (abstract)Google Scholar
  137. Harbert JC, Rocha AFG (1979) Brain scanning. In: Rocha AFG, Harbert JC (eds) Textbook of nuclear medizine: clinical applications. Lea & Febi-ger, PhiladelphiaGoogle Scholar
  138. Harper PV, Lathrop K A, Richards P (1964) 99mTc as radio colloid. J Nucl Med 5:382Google Scholar
  139. Haubold U, Aulbert E (1973) Gallium-67 as a tumor-scanning agent. Clinical and physiological aspects. International Atomic Energy Agency, ViennaGoogle Scholar
  140. Haubold U, Haubold RS, Aulbert E, Ammon J, Marves M (1974) Tumorszintigraphie mit GA 67 und Co 57 — Bleomycin; Indikation und Stellenwert in der radiologischen Tumordiagnostik. Dtsch Röntgen-Kongreβ, Baden-Baden, Sonderband RöfoGoogle Scholar
  141. Hawkes RC, Holland GN, Moore WS, Worthington BS (1980) NMR tomography of the brain. J Computer Assisted Tomogr 4:577–587Google Scholar
  142. Hayes RL (1978) The medical use of gallium radio-nuclides. Semin Nucl Med 8:183–191PubMedGoogle Scholar
  143. Hayes RL, Brown DH (1975) Biokinetics of radiogal-lium. In: Pabst HW (Hrsg) Nuklearmedizin, Fortschritte der Nuklearmedizin in klinischer und technologischer Sicht. Schattauer, New York, S 837–848Google Scholar
  144. Haynie TP, Nofal MM, Beierwaltes WH (1963) Treatment of thyroid carcinoma with 131I-Results at 14 years. JAMA 183:303PubMedGoogle Scholar
  145. Hebestreit HP, Böttger E, Trede M, Bleyl U (1977) Szintigraphische Diagnose eines primären Leberzellkarzinoms mit einem neuen Radiopharmazeu-tikum. Röfo 127:486–488PubMedGoogle Scholar
  146. Heilmann HP, Kunft HD (1970) Hirnszintigraphie und Artdiagnostik. Erfahrungen mit der RISHA-Szintigraphie. Röfo 112:664–675Google Scholar
  147. Heinrich HC (1983) Die Anwendung des Ganzkörper-Radioaktivitätsdetektors in Diagnostik u. Therapie des Eisenmangels. Sympos Rhein-Westf Ges Nukl Med. Der Nuklearmediziner (im Druck)Google Scholar
  148. Hennig K, Woller P, Franke W-G (1967) Erfahrungen bei der Lungenszintigraphie. Fortschr Roent-genstr 107:600–609Google Scholar
  149. Herrera NE, Gonzales R, Schwartz RD, Diggs AM, Belsky J (1965) 75Se-Methionine as a diagnostic agent in malignant lymphoma. J Nucl Med 6:792PubMedGoogle Scholar
  150. Heyes H, Glück D (1977) Die Bedeutung des Fibrins/Fibrinogens für Wachstum und Metastasierung von Malignomen. Klin Wochenschr 55:1079PubMedGoogle Scholar
  151. Higasi T, Nakayama Y (1972) Clinical Evaluation of 67Ga-Citrate scanning. J Nucl Med 13:196–201PubMedGoogle Scholar
  152. Hoffer PB (1980) Gallium and infection. J Nucl Med 21:484PubMedGoogle Scholar
  153. Hoffer PB, Gottschalk A (1974) Tumor scanning agents. Semin Nucl Med 4/3:305Google Scholar
  154. Hoffer PB, Turner DA, Gottschalk A (1973) Whole-body radiogallium scanning for staging of Hodg-kin’s disease and other lymphomas. Natl Cancer Inst Monogr 36:277PubMedGoogle Scholar
  155. Hör G, Maul FD (1980) Gegenwärtiger Stand der onkologischen Diagnostik in der Nuklearmedizin. Der Nuklearmediziner 4:315–326Google Scholar
  156. Hör G, Maul FD, Standke R, Munz D (1981) Scinti-graphy in oncology. In: Medical Radionuclide Imaging. IAEA — SM-247/214, WienGoogle Scholar
  157. Horst W (1951) Zur diagnostischen Anwendung von Radiojod 131. Strahlentherapie 85:183PubMedGoogle Scholar
  158. Hübner KF, King P, Gibbs WD, Partain CL, Waschburn LC, Hayes RL, Holloway E (1981) Clinical investigations with carbon-11-lebelled amino acids using positron emission computerized tomography in patients with neoplastic diseases. In: Medical radionuclide imaging 1980. IAEA-SM 247/90, Wien, p 515Google Scholar
  159. Hünermann B (1982a) Tumormarker in der ärztlichen Praxis. Therapiewoche 32:4105–4115Google Scholar
  160. Hünermann B (1982b) Vergleichende Untersuchungen von 5 Tumormarkern in der ambulanten Tumornachsorge bei Mamma- und Prostatakarzinom. Nuc Compact 13:197Google Scholar
  161. Hünermann B, Janson R, Sobbe A (1971) Zum Problem der Tumorspezifität von Gallium-67 und seiner lokalisationsdiagnostischen Bedeutung. Nuc Compact 9:38–39Google Scholar
  162. Hünermann B, Felix R, Wesener K, Winkler C (1975) Zur Wirkung von Papaverinhydrochlorid auf die Hirnzirkulation. Arzneimittelforsch (Drug Res) 25/4:652–653Google Scholar
  163. Hundeshagen H (1968) Quantitative Organvertei-lungsuntersuchungen nach Applikation mehrerer Radionuklide mit Hilfe der Computerszintigra-phie. In: Fellinger K, Höfer R (Hrsg) Radioisotope in Klinik und Forschung, Bd VIII/1Google Scholar
  164. Hundeshagen H (1975) Value and limitation of com-putercontroiled pancreatic function scintigraphy. In : Anacker H (ed) Efficiency and limits of radio-logic examination of the pancreas. Thieme, Stuttgart, pp 222–229Google Scholar
  165. Hundeshagen H (1976) Doppelradionuklid-Funk-tionsszintigraphie der Bauchspeicheldrüse nach Applikation von Clanobutin. Nuc Compact: 7:2–4Google Scholar
  166. Hundeshagen H (1978a) Nuklearmedizin. In: Diethelm L (Hrsg) Handbuch der medizinischen Radiologie, Bd XV. Springer, Berlin Heidelberg New YorkGoogle Scholar
  167. Hundeshagen H (1978b) Leber-, Galle-, Pankreas-Sequenzszintigraphie mit 99m-Tc-Hepatobida und 75Se-Methionin. In: Höfer R (Hrsg) Radioaktive Isotope in Klinik und Forschung (Gasteiner Intern. Sympsoium 1978, Bd 13. Eger-mann, WienGoogle Scholar
  168. Ito Y, Muranaka A, Harada T, Matsudo A, Yokobayasi T, Terashima H (1978) Experimental study of 201Tl-chloride. Eur J Nucl Med 3:81PubMedGoogle Scholar
  169. Jacobstein JG, Quinn JL III (1973) Uptake of 206Bi citrate in carcinoma of the breast. Radiology 107:677PubMedGoogle Scholar
  170. Jaszczak RJ, Murphy PH, Huard D (1977) Radio-nuclide emission computed tomography of the head with 99mTc and a scintillation camera. J Nucl Med 18:373–380PubMedGoogle Scholar
  171. Jeghers O, Abramovici A, Jonckheer M, Ermans M (1978) A chemical method for the labelling of fibrinogen with 99mTc. Eur J Nucl Med 3:95PubMedGoogle Scholar
  172. Jereb M, Unger B, Jereb B (1973) Demonstration of malignant tumors in the lung and mediastinum by means of radionuclear 75Se scintigraphy. Scand J Respir Dis 54:283–289Google Scholar
  173. Johnston GS, Jones AE, Milder MS, Frankkeil RL (1973) The Gallium-67 scan in clinical assessment of cancer. J Surg Oncol 5:529–537PubMedGoogle Scholar
  174. Jones AG, Francis MD, Davis MA (1976) Bone scanning: radionuclide reaction mechanisms. Semin Nucl Med 6:1Google Scholar
  175. Jones HB, Chaikoff JL, Lawrence JH (1940) 32P uptake of malignant tissue cells. Am J Cancer 40:483Google Scholar
  176. Jung H, Gamm H, Fischer J, Wolf R, Hülse R, Grimm W (1974) Tumorszintigraphie mit 57Co-Bleomycin Nuklearmedizin — Ergebnisse in Technik, Klinik und Therapie. Schattauer, Stuttgart New YorkGoogle Scholar
  177. Kamin PD, Bernardino ME, Green G (1979) Ultrasound manifestations of hepatocellular hepa-toma. Radiology 131:459PubMedGoogle Scholar
  178. Kaplan E, Clayton G, Fink S, Jacobson B, Ben-Po-rath M (1966) Elimination of liver interference from the selenomethionine pancreas scan. J Nucl Med 7:807PubMedGoogle Scholar
  179. Keston AS, Ball RP, Frantz VK, Palmer WW (1942) Radioiodine uptake in metastatic thyroid carcinoma. Science 95:362PubMedGoogle Scholar
  180. Kimmig B, Brandeis WE, Eisenhut M, Bubeck B, Hermann HJ, zum Winkel K (1983) Szintigraphi-sche Darstellung eines Neuroblastoms. NucCompact 14, 347–348Google Scholar
  181. Knapp WH, Helus F, Georgi P, Holzkämper M, Ostertag H, Becker W, Brandeis WE (1981) Utilisation von L-(N-13)-Glutamat bei malignen und benignen ossären Prozessen. In: Schmidt HAE, Rösier H (eds) Nuklearmedizin computer assisted functional analysis. Schattauer, Stuttgart New York, p 222Google Scholar
  182. Knopp R, Winkler C (1974) Ein Szintillationska-mera-Prozeßrechnersystem für die nuklearmedizinische Diagnostik. Kerntechnik 16:372Google Scholar
  183. Knopp R, Biersack HJ, Winkler C (1982) Untersuchungen zur Technik der Kernmagnetresonanz-(NMR)-Tomographie — Parametrische T2-Darstellung (Spin-Spin-Relaxation). Nuc Compact 13:289Google Scholar
  184. Kolberg T, Virnich H, Winkler C (1974) Praeopera-tive Artdiagnostik hirnorganischer Prozesse mit Hilfe eines Computerprogramms. Acta Neurochir (Wien) 31:23Google Scholar
  185. Kosoff G (1972) Improved techniques in ultrasonic cross-sectional echography. Ultrasonics 10:221–227Google Scholar
  186. Kroon HMJ, Pauwels AEK (1982) Knochenszinti-graphie zur Diagnose und Verlaufskontrolle der hypertrophen Osteopathie (M Pierre-Marie-Bamberger). Diagnostic Imaging 51:47PubMedGoogle Scholar
  187. Krüger J, Gross R, Zum Winkel K, Wollensak J, Haubold U, Motzkus F, Fischer G (1970) Stoffwechselstudien an den Melanozyten des Auges mittels 125J-Methioquin. In: Radioaktive Isotope in Klinik und Forschung, Bd 9. Urban & Schwar-zenberg, München, S 409Google Scholar
  188. Lamerz R, Fateh-Moghadam A (1975) Übersichten: Carcinofetale Antigene. II Carcinoembryonales Antigen (CEA). III. Andere carcinofetale Anti-gene. Klin Wochenschr 53:193PubMedGoogle Scholar
  189. Lange RC, Spencer RP, Harder HC (1973) The anti-tumor agent cis-Pt (NH3)2 Cl2 : distribution studies and dose calculations for 193mPt. J Nucl Med 14:191PubMedGoogle Scholar
  190. Langhammer H, Glaubitt G, Grebe SF, Hampe JF, Haubold U, Hör G, Kaul A, Koeppe P, Koppenhagen J, Roedler HP, Schoot JB van der (1972) 67Ga for tumor scanning. J Nucl Med 13:25PubMedGoogle Scholar
  191. Langmann J (1972) Medizinische Embryologie. 2. Aufl., G. Thieme-Verlag, Stuttgart, S. 318Google Scholar
  192. Larson SM (1978) Mechanism of localization of gal-lium-67 in tumors. Semin Nucl Med 8:193–203PubMedGoogle Scholar
  193. Larson SM, Milder MS, Johnston GS (1975) Tumor seeking radiopharmaceuticals: gallium-67. In: Subramanian (eds) Radiopharmaceuticals. Society of Nuclear Medicine, New York, p 413Google Scholar
  194. Lathrop KA, Johnston RE, Blau M, Rothschild ED (1972) Radiation dose to humans from 75Se-L-selenomethionine. J Nucl Med Supp 6:7Google Scholar
  195. Lathrop KA, Harper PV, Rich B (in press) Rapid incorporation of short-lived cyclotron-produced radionuclides into radiopharmaceuticals. In: New Developments in radiopharmaceuticals and labelled compounds. Bevans, CopenhagenGoogle Scholar
  196. Laughlin JS, Gelbard AS, Benua RS, Reiman RE, Rosen G, Allen J, Helson L, Bigler RE, Hopfan S, Dahl JR, Lee R, Schmall B, Myers WG (1981) Report on compounds labelled with nitrogen-13 or carbon-11 used in cancer metabolic studies with quantitative two-dimensional scanning and PET tomography. In : Medical radionuclide imaging 1980. IAEA, Wien SM 247/111Google Scholar
  197. Lauterbur P (1973) Nature 243:190Google Scholar
  198. Law LW, Apella E (1975) Cancer: A comprehensive treatise, vol 4. Plenum, New York, p 135Google Scholar
  199. Lawrence JH (1940) Tumor retention of 32Phosphorus. J Clin Invest 19:267PubMedGoogle Scholar
  200. Lawrence JH, Nelson WO, Wilson H (1937) Artificial Radionuclides. Radiology 29:446Google Scholar
  201. Lehmann FG, Wegener T (1979a) Alpha-fetoprotein in liver cirrhosis. I. Prognostic and diagnostic significance of the transient rise of serum alpha-fetoprotein. In: Lehmann FG (ed) Carcino-Em-bryonic Proteins, vol I. Biomedical Press, Elsevier/North-HollandGoogle Scholar
  202. Lehmann FG, Wegener T (1979b) Alpha-fetoprotein in liver cirrhosis. II. Early detection of hepatoma. In: Lehmann FG (ed) Carcino-embryonic proteins, vol I. Biomedical Press, Elsevier/North-HollandGoogle Scholar
  203. Lewis MR, Goland PH P (1948) Am J Med Sci 215:282PubMedGoogle Scholar
  204. Loewenstein MS, Zamcheck N (1977) Carcinoem-bryonic antigen and the liver. Gastroenterology 72:161PubMedGoogle Scholar
  205. Lomas F, Dibos P, Wagner HN Jr (1972) Increased specificity of liver scanning with the use of 67-gal-lium citrate. N Engl J Med 286:1323PubMedGoogle Scholar
  206. Lommatzsch P, Guntermann S (1971) Über den klinischen Wert des 32-P-Tests bei der Diagnostik intraokularer Tumoren. Ophthalmologica 163:393PubMedGoogle Scholar
  207. Long DM (1970) Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J Neurosurg 32:127–144PubMedGoogle Scholar
  208. Long R, McAfee J, Winkeelman J (1963) Evaluation of radioactive compounds for the external detection of cerebral tumors. Cancer Res 23:98Google Scholar
  209. Low-Beer BVA (1946) Surface measurements of radioactive phosphorus in breast tumors as possible diagnostic method. Science 104:399Google Scholar
  210. Löw A, Hotze A, Mahlstedt J (1983) Nebennieren-mark-Szintigraphie mit 131J-meta-Benzylguani-din. NucCompact 14, 340–346Google Scholar
  211. Löwhagen T, Willems IS, Lundell G, Sunblad R, Granberg PO (1981) Aspiration biopsy cytology in diagnosis of thyroid cancer. World Surg 5:61Google Scholar
  212. Lubin E, Lewitus Z (1972) Blood pool scanning in investigating hepatic mass lesions. Semin Nucl Med 2:128–132PubMedGoogle Scholar
  213. Lundström R, Björklund B, Eklund G (1973) Append 2 A tissue-derived polypeptide antigen: Its relation to cancer and its temporary occurrence in certain infectious diseases. Immunological techniques for detection of cancer. The Folk-sam Symposium, Copyr Bonniers, Stockholm, p 243Google Scholar
  214. Lütgemeier J, Löwe K (1973) Differentialdiagnostische Kriterien der Hilustumoren im Lungenszinti-gramm. Med Welt 24:135–138PubMedGoogle Scholar
  215. Lütgemeier J, Hebestreit HP, Foster P (1972) Postoperative Lymphoszintigraphie beim Mamma-karzinom. Fortschr Geb Roentgenstr Nuklear-med 116:675Google Scholar
  216. Lüthgens M, Schlegel G (1980) CEA + TPA in der klinischen Tumordiagnostik, insbesondere des Mamma-Karzinoms. Tumordiagnostik 2:63Google Scholar
  217. Mach JP, Forni M, Ritschard J, Buchegger F, Carrel S, Widgren S, Donath A, Alberto P (1980) Use and limitations of radiolabeled anti-CEA antibodies and their fragments for photoscanning detection of human colorectal carcinomas. Oncodevel-opmental Biology and Medicine 1:49–69Google Scholar
  218. Magilner AD, Ostrum BJ (1978) CT in the diagnosis of renal masses. Radiology 126:715PubMedGoogle Scholar
  219. Maier R, Pfannenstiel P, Stein N, Hirsch H, Adam W, Utech CHR (1981) Beispiele sonographischer Strukturen bei Schilddrüsenerkrankungen mit eu-thyreoter Stoffwechsellage. Der Nuklearmediziner 4:97Google Scholar
  220. Maisey MN (1981) Methods of investigation in the diagnosis of thyroid carcinoma. World J Surg 5:49PubMedGoogle Scholar
  221. Marchesi F, Maneschi M, Cittadini E (1962) ’I1 test delia fosfocaptazione cervicale del 32P con conta-tore anton in subminiature nella diagnosi del carcinoma della portio. Attual Ostet Ginec 8:277Google Scholar
  222. Matter AG, Prezio JA (1975) Visualization of pancreatic pseudocyst. J Nucl Med 16:326Google Scholar
  223. Matzku S, Mattern J, Georgi P, Hellström I (1982) Radioimmunolocalization of melanomas with monoclonal anti-bodies directed against the p97 marker. Model experiments in vitro and in nude mice bearing transplanted human melanomas. In: Höfer R, Bergmann H (eds) Radioaktive Isotope in Klinik und Forschung. Egermann, WienGoogle Scholar
  224. Mayneord W, Turner R, Newberry S, Hodt H (1951) A method of making visible the distribution of activity in a source of ionizing radiations. Nature 168:762Google Scholar
  225. McCarthy DM (1972) 75Se-Methionine scanning in the diagnosis of tumors of the pancreas and adjacent viscera. Gut 13:75PubMedGoogle Scholar
  226. McCready VR (1972) Scintigraphic studies of space-occupying liver disease. Semin Nucl Med 2:108–127PubMedGoogle Scholar
  227. Menendez-Botet CJ, Oettgen HF, Pinsky CM, Schwartz MK (1978) A priliminary evaluation of tissue polypeptide antigen in serum or urine (or both) of patients with cancer or benign neoplasms. Clinical Chemistry 6:868Google Scholar
  228. Merrick MV (1973) Zit n Hoffer B. Semin Nucl Med 4:310Google Scholar
  229. Moore G (1947) Fluorescein as an agent in the differentiation of normal and malignant tissues. Science 106:130PubMedGoogle Scholar
  230. Moore GE (1948) Use of radioactive diiodofluores-cein in diagnosis and localization of brain tumors. Science 107:569PubMedGoogle Scholar
  231. Moore GE, Peyton WT, French LA, Walker WW (1948) Clinical use of sodium fluorescein and radioactive diiodofluorescein in localization of tumors of central nervous system. Minn Med 31:1073PubMedGoogle Scholar
  232. Moore GE, Smith GA, Caudill CM, Marvin JF, Aust JB (1951) Clinical and experimental studies of in-tracranial tumors with fluorescein dyes. With additional note concerning the possible use of 42-K and 131-I tagged human albumin. Am J Radiol Rad Ther 66:8Google Scholar
  233. Moore WS, Holland GN (1980) Nuclear Magnetic Resonance Imaging. Br Med Bull 36:297–299PubMedGoogle Scholar
  234. Mori T, Hamamoto K, Onoyama Y, Roizuka K (1975) Tumor imaging after administration of 99mTc-labeled bleomycin. J Nucl Med 16:414PubMedGoogle Scholar
  235. Muehllehner G, Atkins F, Harper PV (1977) Positron camera with longitudinal and transverse tomo-graphic capibilities. In: Medical radionuclide imaging. Vol 1. IAEA, Wien, p 291Google Scholar
  236. Mulhern CB, Arger PH, Coleman BG (1980) Pancreatic Imaging. In: Alavi A, Arger PH (eds) Procedures, nuclear medicine, ultrasound. Grune & Stratton, New YorkGoogle Scholar
  237. Müller JH (1961) Tumordiagnostik. In: Schwiegk H, Turba F (Hrsg) Künstliche radioaktive Isotope in Physiologie, Diagnostik und Therapie. Springer, Berlin Göttingen HeidelbergGoogle Scholar
  238. Müller-Schauenburg W (1980) Elektronische Datenverarbeitung. In: Nuklearmedizinische Szintigra-phische Diagnostik, 2. Aufl. Thieme, StuttgartGoogle Scholar
  239. Mundinger F, Gerhard H (1963) Untersuchungen zur Verteilung der zur Hirntumordiagnostik verwendeten Radioisotope im Blut und in Hirngeschwülsten. Acta Neurochir (Wien) 11:398Google Scholar
  240. Munz RL, Altmeyer P, Holzmann H, Encke A, Hör G (1982) Der Stellenwert der Lymphoszintigra-phie in der Behandlung maligner Melanome der Haut. Dtsch Med Wochenschr 107:86PubMedGoogle Scholar
  241. Münzel M, Schmode G (1969) Zur Problematik der szintigraphischen Darstellung von Parotistumo-ren mit Technetium-99m. Z Laryng Rhinol 48:491–495Google Scholar
  242. Myant NB, Hilton G, Honour AJ, Corbett BD (1952) Indications for radioiodine treatment of thyroid carcinoma. Br Med J 2:1115PubMedGoogle Scholar
  243. Nardo GL de, Volpe JA (1966) Detection of bone lesions with strontium-85 scintiscan J Nucl Med 7:219–236Google Scholar
  244. Nardo S de, Nardo GL de, Swanson MA, Trelford K, Krohn K A (1979) Efficiacy of highly iodinated fibrinogen in patients with cancer. J Nucl Med 20:645Google Scholar
  245. Newman ES, Petras SE, Georgiadis A (1974) Interrelationship of carcinoembryonic antigen and colon carcinoma antigen III. Cancer Res 34:2125–2130PubMedGoogle Scholar
  246. Nishi S (1970) Isolation and characterization of a human fetal alphaglobulin from the sera of fetuses and a hepatoma patient. Cancer Res 30:2507–2513PubMedGoogle Scholar
  247. Nouel JP, Renault R, Robert J, Jeanne C, Wicart L (1972) La bleomycine marqueé au Co-57. Nouv Press Med 1:95Google Scholar
  248. Nowak D, Hilweg D (1971) Häufigkeit und Formen intrathorakaler Manifestation maligner Lym-phome. Dtsch Med Wochenschr 96:230–234Google Scholar
  249. O’Connor MK, Cullen MJ, Malona JF (1977) A kinetic study of (131-I)-iodide and (99m-Tc)-per-technetate in thyroid cancer to explain a scan discrepancy: Case report. J Nucl Med 18:796PubMedGoogle Scholar
  250. Oehr P, Hamann D, Klar R, Schlösser T, Winkler C (1980) Serumkonzentrationen von Tissue Polypeptide Antigen und Tennessee-Antigen im Vergleich zu CEA, AFP und β-HCG bei Patienten mit Harnblasen- und Hodencarcinomen. Nuc Compact 11:223Google Scholar
  251. Oehr P, Derigs G, Altmann R (1981) Evaluation and characterization of tumor-associated antigens by conversion of inverse distribution function values into specificity-sensitivity diagrams. Tumor Diagnostik 2:283Google Scholar
  252. Oehr P, Biersack HJ, Kersjes W, Kunath U (1982) Die Bestimmung des Carcinoembryonalen Antigens — Ein Vergleich von drei Methoden anhand der inversen Verteilungsfunktion und des Sen-sitivitäts-Spezifitätsdiagramms. Nuc Compact 13:63Google Scholar
  253. Oehr P, Björklund B, Reichmann K, Grönland H, Back M, Maisey R, Odenthal U, Lafrenz T, Biersack HJ, Winkler C (1983a) Radioimmuno detection (RID) by anti-TPA antibodies. Abstr Titel 21. Jahrestagung der Ges für Nuklearmedizin Europa, 1983Google Scholar
  254. Oehr P, Weißbach L, Figge M, Derigs G (1983 to be published) Specificity and sensitivity of human chorionic gonadotropin radioimmunoassays. A comparison of 2 different approaches. Urol IntGoogle Scholar
  255. Oeser H, Ernst H, Gerstenberg E (1970) Die wandlungsfähigen Röntgenzeichen des neutralen Bron-chuskarzinoms. DMW 95:552–557Google Scholar
  256. Old LJ (1981) Cancer immunology: The search for specificity. Cancer Res 41:361–375PubMedGoogle Scholar
  257. Otto DL, Horwitz NH, Kurtzmann RS, Ofstrom JE (1964) Radioactive I131 and P32 as aids in the diagnosis of lesions of the stomach. Am J Roent-genol 91:784Google Scholar
  258. Palumbo R, Tonato M, Martelli MF, Corso S, Allerga A, Crinol, Grigani F (1974) 67Ga scanning in the staging of Hodgkin’s disease. Acta Haema-tol (Basel) 52:280Google Scholar
  259. Parchwitz HK, Winkler C (1957) Speicherung organischer Farbstoffe und künstlich radioaktiver Substanzen in Geschwülsten. In : Brandt L (Hrsg) Forschungsberichte des Wirtschafts- und Verkehrsministeriums NRW, Nr 414. Westdeutscher Verlag, Köln OpladenGoogle Scholar
  260. Paterson AH, McCready VR (1975) Tumor Imaging radiopharmaceuticals. Br J Radiol 48:520–531PubMedGoogle Scholar
  261. Pendergrass HP, Potsaid MS, Castronovo FP (1973) The clinical use of 99mTc-diphosphonate (HEDSPA). Radiology 107:557–562PubMedGoogle Scholar
  262. Pfannenstiel P (1979a) Stellenwert der Schilddrüsenzytologie bei der Indikationsstellung zur Operation. Langenbecks Arch 349:123Google Scholar
  263. Pfannenstiel P (1979b) Kritische Bewertung der Schilddrüsenszintigraphie. Med Klin 72:1Google Scholar
  264. Pfannenstiel P (1982) Probleme der Diagnostik von Schilddrüsenkarzinomen. In: Biersack HJ, Winkler C (Hrsg) Neue Aspekte in Diagnostik und Therapie des Schilddrüsenkarzinoms. Schattauer, Stuttgart New YorkGoogle Scholar
  265. Pfeiff A, Stäudner R (1967) Voraussetzungen und Möglichkeiten der Anwendung von Miniatur-Halbleiterdetektoren zur Tumordiagnostik. In: Winkler C (Hrsg) Entwicklung, Methoden, Ergebnisse. Nuklearmedizin, Akademischer Verlag, Bonn, S 115Google Scholar
  266. Pineda G, Clauria H, Rocha AFG, Harbert JC (1979) The thyroid. In: Rocha AFG (ed) Textbook of Nuclear Medicine. Lea & Febiger, PhiladelphiaGoogle Scholar
  267. Pinsky S, Bekerman C, Hoffer P (1978) In: Greenfield LD (ed) Thyroid cancer. CRC USAGoogle Scholar
  268. Planiol Th (1966) Some aspects of brain-investigation by means of radioisotopes. J Neurol Sci 3:539–564Google Scholar
  269. Pochin EE (1959) Profile Counting. In: Medical Radioisotope Scanning. International Atomic Energy Agency, Vienna, p 143Google Scholar
  270. Pochin EE (1967) Prospects from the treatment of thyroid carcinoma with radioiodine. Clin Radiol 18:113–125PubMedGoogle Scholar
  271. Pochin EE (1971) Radioiodine therapy of thyroid cancer. Semin Nucl Med 1:503PubMedGoogle Scholar
  272. Pochin EE (1951) zit n Pochin EE. Radioiodine therapy of thyroid cancer. Semin Nucl Med 1:503Google Scholar
  273. Pochin EE, Cunningham RM, Hilton GW (1954) Quantitative measurements of radioiodine reten-sion in thyroid carcinoma. J Clin Endocrin 14:1300Google Scholar
  274. Polterauer P, Müller M (1982) α 1-Fetoprotein und Tennessee-Antigen bei hepatozellulären Karzinomen und bei der Metastasenleber. Wien Klin Wo-chenschr 4:102Google Scholar
  275. Potter TP Jr, Lasater HA, Jordan TA, Jordan JD, Johnston RK, Oishi N (1980) Tennessee Antigen — clinical application. Cancer prevention and detection, vol 13 (in press)Google Scholar
  276. Pressman D (1980) The development and use of ra-diolabeled antitumor antibodies. Cancer Res 40:2960–2964PubMedGoogle Scholar
  277. Pressman D, Korngold L (1953) The in vivo localization of anti-Wagner-Osteogenic-Sarcoma antibodies. Cancer 6:619–623PubMedGoogle Scholar
  278. Purcell EM (1946) Resonance absorption by nuclear magnetic moments in a solid. Phys Rev 69:37Google Scholar
  279. Quinones J, Mizejewski G, Beierwaltes WH (1971) Choriocarcinoma scanning using radiolabeled antibody to chorionic gonadotrophin. J Nucl Med 12:69PubMedGoogle Scholar
  280. Raimondi AJ (1964) Localization of radioiodinated serum albumin in humanglioma. An electron-microscopic study. Arch Neurol 11:173–184PubMedGoogle Scholar
  281. Ramos M, Buri P, Rösier H (1976) Die Leistungsfähigkeit der Lungenszintigraphie in der Abklärung des Bronchialkarzinoms (Prospektive Studie zur TN-Stadieneinteilung). Schweiz Med Wo-chenschr 106:134–141Google Scholar
  282. Ramos M, Zurbriggen S, Vock P, Buri P (1977) Bedeutung und Stellenwert der Thorax-Übersichtsaufnahme und der Lungenszintigraphie für die Diagnose und Stadieneinteilung des Bronchialkarzinoms. Schweiz Med Wochenschr 107:915–923PubMedGoogle Scholar
  283. Reddy MN, Rochman H, Hunter RL, Fang VS, De Meester T (1979) Carcinoembryonic antigen, k-casein and β-human chorionic gonadotropin in the staging of lung cancer. In : Lehmann F-G (ed) Carcino-embryonic proteins, vol II. Elsevier, Amsterdam New York Oxford, p 173Google Scholar
  284. Reichmann K, Knopp R, Biersack HJ, Winkler C (1982) Schilddrüsen-Szintigraphie-Untersuchun-gen über die Abbildungseigenschaften einer Gam-makamera mit und ohne Spezialkollimator im Vergleich zu denen eines Scanners. Nuc Compact 13:170Google Scholar
  285. Reiman RE, Benua RS, Gelbard AS, Allen J, Vomero JJ, Laughlin JS (1980) Uptake of 13N by brain tumors following administration of 13N-L-glutamate. J Nucl Med 21:22Google Scholar
  286. Renault H, Henry R, Rapin J, Hegesippe (1973) Chelation de cations radioactives par un polypep-tide. Colloque sur les Nouveautés en Matiere de Radiopharmaceutiques et de composés Marqués. Copenhague, March 26–30Google Scholar
  287. Reske SN, Koischwitz D, Biersack HJ, Winkler C (1982) Accumulation of 99mTcMethylendiphos-phonate in liver metastasis (case report). Nuc Compact 13:165–168Google Scholar
  288. Robertson DM (1976) Radioactive Phosphorus uptake testing of chorioideal lesions. Br J Ophthal-mol 60:835Google Scholar
  289. Rosen G, Gelbard AS, Benua RS, Laughlin JS, Reiman RE, McDonald JM (1979) 13N glutamate scanning to detect the early response of primary bone tumors to chemotherapy. AACR 763:189 (abstracts)Google Scholar
  290. Rösier H, Kinser J, Stalder A (1972) Type-specific tumor patterns in cerebral sequential scintigra-phy. Neuroradiology 3:144Google Scholar
  291. Rösier H, Baumgartner MW, Ramos M, Zuppinger A (1973) Ergebnisse der kombinierten 133Xe/99m-Tc-MAP-Lungenszintigraphie beim Bronchialkarzinom. Eine retrospektive und prospektive Studie. Schweiz Med Wochenschr 103:1034–1042Google Scholar
  292. Rost A, Neppenberg UK, Rost P (1976) Wertigkeit des karzinoembryonalen Antigens (CEA) für die Diagnostik maligner Tumoren des Urogenitaltraktes. Helv Chir Acta 43:271PubMedGoogle Scholar
  293. Roswitt JB, Sorrentino J, Yalow R (1950) The use of radioactive phosphorus in the diagnosis of tes-ticular tumors. J Urol 63:724Google Scholar
  294. Sagar VV, Meckelnburg RL, Chaikin HL (1980) Bone scan in rhabdomyolysis. Clin Nucl Med 5:321–322PubMedGoogle Scholar
  295. Sagel SS, Stanley RJ, Levitt RG, Geisse G (1977) CT of the kidney. Radiology 124:359PubMedGoogle Scholar
  296. Saito H (1964) Whole body iron loss measured with a gamma spectrometer. J Nucl Med 5:571PubMedGoogle Scholar
  297. Schatz H, Grebe SF (1982) Die Bedeutung der Thy-reoglobulinbestimmung für die Verlaufskontrolle bei Patienten mit differenziertem Schilddrüsenkarzinom. In: Biersack HJ, Winkler C (Hrsg) Neue Aspekte in Diagnostik und Therapie des Schilddrüsenkarzinoms. Schattauer, Stuttgart New York, S 127Google Scholar
  298. Scheible W (1980) Real time ultrasonography in abdominal disease. In: Alavi A, Arger PH (eds) Multiple imaging procedures, vol 3. Grune & Stratton, New YorkGoogle Scholar
  299. Schenck P (1966) Szintigraphische Dasrstellung des parasternalen Lymphsystems. Strahlentherapie 130:504PubMedGoogle Scholar
  300. Schepers H, Winkler C (1964) An automatic scanning system, using a tape perforator and computer techniques. In: Medical Radioisotope scanning, IAEA Wien, p 321Google Scholar
  301. Schermuly W, Behrend H, Pöhls PH (1975) Die 67Ga-Szintigraphie bei der Sarkoidose. Fortschr Röntgenstr 122:54Google Scholar
  302. Schmitt EJ (1979) Zur Diagnostik intraokularer Tumoren mit dem 32P-Test. Klin Monatsbl Augen-heilkd 174:408Google Scholar
  303. Schütze R, Klar E (1951) Fluorescein zur intraoperativen Abgrenzung von Hirntumoren. Chirurg 22:4Google Scholar
  304. Seiverstone B, White JC (1951) Evaluation of the radioactive mapping technic in the surgery of brain tumors. Ann Surg 134:387Google Scholar
  305. Sfakianakis GN, Deland FH (1982) Radioimmuno-diagnosis and Radioimmunotherapy. J Nucl Med 23:840–850PubMedGoogle Scholar
  306. Shields JA (1978) zit n Strötges MW. Der Nuklearmediziner. 4:373Google Scholar
  307. Shoop JD (1969) Functional hepatoma demonstrated with rose bengal scanning. Am J Roentgenol 107:51Google Scholar
  308. Shukla SK, Castelli L, Blotta I, Manni GB, Cipriani C (1982) Mechanism of gallium-67 uptake in tumors. In: Höfer R (Hrsg) Radioaktive Isotope in Klinik und Forschung, Bd. 15. Gasteiner Internat Symp 1982Google Scholar
  309. Silberstein EB (1976) Cancer Diagnosis: The role of tumor-imaging radiopharmaceuticals. Am J Med 60:226–236PubMedGoogle Scholar
  310. Sisson JC, Frager MS, Valk TW, Gross MD, Swanson DP, Wieland M, Tobes C, Beierwaltes WH, Thompson NW (1981) Scintigraphic Localization of Pheochromocytoma. New Engl. J. Med. 305, 12PubMedGoogle Scholar
  311. Sisson JC, Frager MS, Wieland MC, Beierwaltes WH (1984) Radiopharmaceutical Treatment of Malignant Pheochromocytoma. J. Nucl. Med. 25, 197PubMedGoogle Scholar
  312. Smith FW, Gilday DL, Ash JM (1980) Primary neu-roblastoma uptake of Tc-99m-Methylene Di-phosphonate. Radiology 137:501–504PubMedGoogle Scholar
  313. Sodee DB (1967) The evaluation of metastatic thyroid carcinoma with technetium-99m pertechne-tate. Radiology 88:145PubMedGoogle Scholar
  314. Sodee DB, Cliffton D (1964) Selective neoplasm localization with Mercury-197 Chlormerodrin. In: Brown DW (ed) Scintillation scanning in clinical medicine. Saunders, PhiladelphiaGoogle Scholar
  315. Spar NG (1976) An immunologic approach to tumor imaging. Semin Nucl Med 6:379PubMedGoogle Scholar
  316. Spencer RP (1965) Simultaneous use of two radioisotopes by scanner plus analogue computer coupling. J Nucl Med 6:844–846PubMedGoogle Scholar
  317. Spencer RP (1977) Clinical Laboratory science. In: Seligson D (ed) Section A: Nuclear medicine I, 339. CRC Press, Cleveland/OhioGoogle Scholar
  318. Staab HJ, Anderer FA, Ahlemann LM, Frommhold W (1979) CEA monitoring and management of patients with carcinomas of the breast, lung, bladder, kidney and esophagus in radiotherapy. In: Lehmann F-G (ed) Carcino-embryonic proteins, vol II. Elsevier, Amsterdam New York Oxford, p 151Google Scholar
  319. Stalder A, Kinser J, Rösier H, Schnaars P, Huber P (1972) Type-specific tumor patterns in the cerebral radioangiography (CRAG): Results in 195 patients. Neuradiology 3:137Google Scholar
  320. Stanbury JB, Groot LJ de (1973) Methods in cancer research. In : Busch H (ed) Academic Press, New York, pp 129–159Google Scholar
  321. Steinberg M, Cavalieri RR, Choy SH (1970) Uptake of technetium 99m-Pertechnetate in a primary thyroid carcinoma. Need for caution in evaluating nodules. J Clin Endocrin 31:81–84Google Scholar
  322. Stevenson JC, Hilliard CJ (1980) Tumor markers. In: Duncan W (ed) Thyroid cancer, Vol 73 Rec Res Canc Res. Springer, Berlin Heidelberg New YorkGoogle Scholar
  323. Stirrett L, Yuhl AET, Cassen B (1954) Clinical-applications of hepatic radioactivity survey. Am J Gas-troent 21:310Google Scholar
  324. Strötges MW (1980) Die intraoperative nuklearmedizinische Diagnostik von Melanoblastomen des Auges. Der Nuklearmediziner 4:373Google Scholar
  325. Subramanian G, McAfee IG (1971) A new complex of 99mTc for skeletal imaging. Radiology 98:192–196Google Scholar
  326. Subramanian G, McAfee IG, Blair RJ, Kallfelz FA, Thomas FD (1975) Technetium-99m-Methylene diphosphonate — a superior agent for skeletal imaging: Comparison with other technetium complexes. J Nucl Med 16:986–989Google Scholar
  327. Sullivan DC, Taylor JW, Gottschalk A (1977) The use of ultrasound to enhance the diagnostic utility of the equivocal liver scintigraph. J nucl Med 18:621Google Scholar
  328. Suzuki T, Matsumoto Y, Manabe T, Honjo I, Hamamoto K, Torizuka T (1974) Serum alpha-fetopro-tein and 67Ga citrate uptake in hepatoma. Am J Roentgenol 120:627–633Google Scholar
  329. Swartzendruber DC, Nelson B, Hayes RL (1971) 67Gallium localization in lysosomal-like granules of leukemie and nonleukemie murine tissues. J Natl Cancer Inst 46:941PubMedGoogle Scholar
  330. Swift TR, Brown RM (1978) Tc-99m-Pyrophosphate muscle labelling in McArdie syndrome. J Nucl Med 19:295–297PubMedGoogle Scholar
  331. Tailor KZ, Sullivan D, Rosenfield AT (1977) Gray scale ultrasound and isotope scanning: Complimentary techniques for imaging the liver. Am J Roentgenol 128:277–281Google Scholar
  332. Taplin GV, Johnson DE, Dore EK, Kaplan HS (1964) Lung photoscans with macroaggregates of human serum radioalbumin. Health Phys 10:1219–1227PubMedGoogle Scholar
  333. Taplin GV, Griswald ML, Hurwit J, Johnson DE (1967) Radioalbumin suspensions of high specific activity and more uniform size. J Nucl Med 8:303Google Scholar
  334. Tator CH, Morley TP, Olszewski J (1965) A study of the factors responsible for the accumulation of radioactive iodinated human serum albumin (RIHSA) by intracranial tumors and other lesions. J Neurosurg 22:60–76PubMedGoogle Scholar
  335. Taylor DM, Cottrall MF (1975) Comparison of 37Co-, 62Zn-, and 111In-bleomycin complexes for tumor localization. In: Subramanian G, (eds) Ra-diopharmaceuticals. Society of Nuclear Medicine, New York, p 458Google Scholar
  336. Tefft M (1960) Radioisotopes in malignancies in children. Use in the study of involvement by primary and metastatic processes in brain and liver. J Am Med Assoc 207:1853–1958Google Scholar
  337. Velde ER Te Kroon RA de, Bœuff JA du, Persijn JP, Hagenaars AM, Zegers BJM, Ballieux RE (1979) Studies on serum levels of carcinoembry-onic antigen, alpha-fetoprotein, human chorionic gonadotrophin and alpha-2-pregnancy associated glycoprotein in patients with invasive cervical cancer. In: Lehmann F.-G (ed) Carcino-embry-onic proteins, vol II, Elsevier, Amsterdam New York Oxford, p 185Google Scholar
  338. Thomas CI, Krohmer JS, Storaasli JP (1952) Detection of intraocular tumors with radioactive phosphorus. AMA Arch Ophthal 47:276Google Scholar
  339. Thomas RL, Berns D, Smith GL (1968) The demonstration of an insulin and gastrin producing pancreatic tumor by angiography and pancreatic scanning. Am J Roentgenol 104:646Google Scholar
  340. Thrupkaew AK, Henkin RE, Quinn JL III (1974) False negative bone scans in disseminated metastatic disease. Radiology 113:383PubMedGoogle Scholar
  341. Trier HG (1978) Der Entwicklungsstand der rechnergestützten Gewebsdifferenzierung mit Ultraschall bei der intraokularen Tumordiagnostik. Reprint from the volume of reports, 11th Hellenic Oph-thalmological Congress, Thessaloniki, June 1978Google Scholar
  342. Turner AG, Carter S, Higgins E, Glashan W, Munro Neville A (1977) The clinical diagnostic value of the carcinoembryonic antigen (CEA) in haematuria. Br J Urol 49:61PubMedGoogle Scholar
  343. Turner DA, Pinsky SM, Gottschalk A (1972) The use of 67Ga scanning in the staging of Hodgkin’s disease. Radiology 104:97PubMedGoogle Scholar
  344. Turner DA, Fordham EW, Ali A (1978) Gallium-67 imaging in the management of Hodgkin’s disease and other malignant lymphomas. Semin Nucl Med 8:205PubMedGoogle Scholar
  345. Tyson IB, Deutsch SD, Gandsman EJ, Winkler ML (1982) Dynamic bone scanning in the differential diagnosis of skeletal lesions. In : Höfer R (Hrsg) Radioaktive Isotope in Klinik und Forschung. Egermann, WienGoogle Scholar
  346. Ueda R, Shiku H, Pfreundschuh M, Takahashi T, I LTC, Whitmore WF, Oettgen HF, Old LJ (1979) Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med 150:564–579PubMedGoogle Scholar
  347. Ueno K, Haseda Y (1980) Concentration and clearance of 99mTc-Pyrilidoxylidene Isoleucine by a hepatoma. Clin Nucl Med 5:196–198PubMedGoogle Scholar
  348. Umezawa HY, Suharia Y, Takita T, Maeda K (1966) Purification of bleomycins. J Antibiot (Tokyo) 19:210Google Scholar
  349. Umezawa H, Ishizuka M, Hori S (1968) Distribution of 3H-bleomycin in mouse tissue. J Antibiot (Tokyo) 38:642Google Scholar
  350. Van Herle AJ (1978) Pathophysiology of thyroid cancer. In: Greenfield LD (ed) Thyroid cancer. CRC Cleveland/OhioGoogle Scholar
  351. Verheyden ChN, Heerden JA van, Carney JA (1974) Symptomatic metastatic melanoma of the spleen. Minn Med 57:693PubMedGoogle Scholar
  352. Verma RC, Bennett LR, Touya JJ (1973) 111Indium-bleomycin : A new radiopharmaceutical for tumor scintigraphy. J Nucl Med 14:641Google Scholar
  353. Virnich H, Winkler C (1976) Das Bayes’sche Theorem in der medizinischen Diagnostik. Methods Inf Med 4:211–216Google Scholar
  354. Wagner HN, Lopez-Majano V, Langan K, Joshi RC (1968) Radioactive xenon in the differential diagnosis of pulmonary embolism. Radiology 91:1168PubMedGoogle Scholar
  355. Washburn LC, Sun TT, Byrd BL (1979) High level production of C-11-Carboxyl-labeled amino acids. In : Society of Nuclear Medicine New York (ed) Radiopharmaceuticals II. Proc 2nd International Symposium on Radiopharmaceuticals. Seattle, Washington, p 767Google Scholar
  356. Wassermann A v, Keysser F, Wassermann M (1972) Berl Med W 49:4Google Scholar
  357. Weir DM (1967) Experimental immunology. Davis, Philadelphia, p 258Google Scholar
  358. Weiss W (1978) Klinische Relevanz der AFP-Bestimmung im Serum. Oncology 1:6–14Google Scholar
  359. Weissleder H, Pfannenstiel P (1979) Endolymphatische Radionuklidbehandlung. In: Emrich D (Hrsg) Nuklearmedizin, Funktionsdiagnostik und Therapie. Thieme, StuttgartGoogle Scholar
  360. Whitley JE, Witcofski RL, Bolliger TT (1966) 99mTc in visualization of neoplasm outside brain. AJR 96:706–710Google Scholar
  361. Wieland DM, Wu JI, Brown LE, Mangner TJ, Swanson DP, Beierwaltes WH (1980) Radiolabeled Adrenergic Neuron-Blocking Agents : Adrenome-dullary Imaging with 131I Iodobenzylguanidine. J. Nucl. Med. 21, 349PubMedGoogle Scholar
  362. Willerson JT, Parkey RW, Bonte FJ (1980) Pathophysiological considerations and clinicopathological correlates of Tc-99m stannous pyrophosphate myocardial scintigraphy. Semin Nucl Med 10:54–69PubMedGoogle Scholar
  363. Winkel K Zum (1964) Nierendiagnostik mit Radioisotopen. Thieme, Stuttgart New YorkGoogle Scholar
  364. Winkel K Zum (1972) Lymphologie mit Radionukliden. Hoffmann, BerlinGoogle Scholar
  365. Winkel K Zum, Pritwitzer U, Jancke T, Schnyder UW (1972) Lymphoszintigraphie beim malignen Melanom. Hautarzt 23:394Google Scholar
  366. Winkler C (1950) Radioaktives Jod zur Behandlung bösartiger Schilddrüsengeschwülste. Verh Dtsch Ges Inn Med 56: XXVIIGoogle Scholar
  367. Winkler C (1960) Radioisotopendiagnostik durch Szintigraphie. Medizin heute 1:5–8Google Scholar
  368. Winkler C (1965a) Über die Nutzung gerinnungs-physiologischer und immunologischer Prozesse zur Radioaktivitätsanreicherung in Tumoren. In: Hoffmann G (Hrsg) Radionuklide in der klinischen und experimentellen Onkologie. Schattauer, Stuttgart, S 349Google Scholar
  369. Winkler C (1965b) Computer-Szintigraphie. Excerpta Med Intern Congr Series, Amsterdam. Proc XL Intern Congr Radiol 105:1165–1170Google Scholar
  370. Winkler C (1973) Computer assisted differential diagnosis of human brain lesions. Internat Res Comm Syst, 16-23-2 (73-12)Google Scholar
  371. Winkler C (1974a) Lungenszintigraphie in der Diagnostik des Bronchialkarzinoms. Roentgenblaetter 27:173–180Google Scholar
  372. Winkler C (1975) Potentials and limits of pancreatic scintigraphy. In: Anacker H (ed) Efficiency and limits of radiologic examination of the Pancrreas. Thieme, Stuttgart, p 229Google Scholar
  373. Winkler C (1980) Vergleich der szintigraphischen Bilddarstellungs- bzw. Ausgabeverfahren. Der Nuklearmediziner. Meßtechnik 2:113–120Google Scholar
  374. Winkler C (1983a) (im Druck) Schilddrüsenszintigraphie mit der GammakameraGoogle Scholar
  375. Winkler C (1983b) (im Druck) NMR-Tomographie in der TumordiagnostikGoogle Scholar
  376. Winkler C, Kolberg T (1979) Elektronische Datenverarbeitung in der Diagnostik hirnorganischer Prozesse. Der Nuklearmediziner 2:182–188Google Scholar
  377. Winkler C, Reichmann K (1983) Vergleichende Untersuchungen zur Schilddrüsenszintigraphie mit Gammakamera und Scanner. Acta Endocrin 4:60–62Google Scholar
  378. Winkler C, Düx A, Bücheier E (1972) Vergleichende vasographische und szintigraphische Untersuchungen zum Nachweis von Lebertumoren. In: Diethelm W (Hrsg) Angiographie/Szintigraphie. Springer, Berlin, S 213Google Scholar
  379. Wohlenberg H (1977) Stellenwert der Feinnadelbiopsie in der Schilddrüsendiagnostik. Therapiewoche 27:4669Google Scholar
  380. Wolf F, Krönert E (1978) Leber und Gallenwege. In: Handbuch der Radiologie, Bd XV. Springer, Berlin Heidelberg New YorkGoogle Scholar
  381. Wolf R, Fischer J (1965) Szintigraphische Untersuchungen mit 197HgCl2. In: Deutscher Röntgen-kongreß 1964, Teil A. Thieme, StuttgartGoogle Scholar
  382. Wolf W, Berman JA, Shani J (1975) Radiopharma-cokinetics of 5-fluorouracil. J Nucl Med 16:582Google Scholar
  383. Wolfsen A, Odell W (1982) Advances in the use of peptide hormones as tumor markers. In: Steckel J, Kagan R (eds) Cancer diagnosis new concepts and techniques. Grune & Stratton, New YorkGoogle Scholar
  384. Woodbury RG, Brown JP, Yeh MY (1980) Identification of a cell surface protein, p 97, in human melanomas and certain other neoplasms. Proc Natl Acad Sci USA 77:2183–2187PubMedGoogle Scholar
  385. Wright RL (1967) Vascular permeability in experimental brain tumors. Angiology 18:69PubMedGoogle Scholar
  386. Wright T, Sinanan M, Harrington D (1979) Immunoglobulin: applications to scanning and treatment. Appl Radiol/NM 120–124Google Scholar
  387. Würz H, Schulte M, Schulz K-D, Schmidt-Rhode P, Geiger W (1981) Radioimmunologische Bestimmung des schwangerschaftsassoziierten α 2-Glykoproteins (α 2PAG) bei Patientinnen mit Mamma- und Genital-Karzinomen. In: Uhlenbruck G, Wintzer G (Hrsg) CEA — Carcinoem-bryonales Antigen und andere Tumormarker. Tumordiagnostik, Leonberg, S 358Google Scholar
  388. Yeh SH, Shih WJ, Liang JC (1973) Intravenous radionuclide hepatography in the differential diagnosis of intrahepatic mass lesions. J Nucl Med 14:565–567PubMedGoogle Scholar
  389. Zülch KJ (1968) Biologie und Pathologie der Hirngeschwülste. In: Handbuch der Neurochirurgie, Bd III. Springer, Berlin Heidelberg New YorkGoogle Scholar
  390. Zurowski S, Graban WT, Jakubowski W (1977) Fully automatic computer-assited pancreas imaging. Eur J Nucl Med 2:273PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1985

Authors and Affiliations

  • C. Winkler

There are no affiliations available

Personalised recommendations